Revival of plasmin as a therapeutic agent?
Collen
D
D
Center for Molecular and Vascular Biology, University of Leuven, Belgium. desire.collen@med.kuleuven.ac.be
D000818:Animals; D001012:Aorta, Abdominal; D001018:Aortic Diseases / Q000188:drug therapy; D003001:Cloning, Molecular; D005341:Fibrinolysin / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D010958:Plasminogen / Q000032:analysis; D011817:Rabbits; D011994:Recombinant Proteins / Q000627:therapeutic use; D015912:Thrombolytic Therapy / Q000639:trends; D013927:Thrombosis / Q000188:drug therapy*; D000979:alpha-2-Antiplasmin / Q000032:analysis
D011994:Recombinant Proteins; D000979:alpha-2-Antiplasmin; D010958:Plasminogen; D005341:Fibrinolysin